GRANULES INDIA Financial Statement Analysis
|
||
|
The Revenues of GRANULES INDIA have increased by 19.84% YoY .
The Earnings Per Share (EPS) of GRANULES INDIA has decreased by -21.65 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GRANULES INDIA Last 5 Annual Financial Results
[BOM: 532482|NSE : GRANULES]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹4,512 Cr | ₹3,765 Cr | ₹32,375 Cr | ₹2,599 Cr | ₹2,279 Cr |
| Expenses | ₹3,599 Cr | ₹3,043 Cr | ₹23,823 Cr | ₹2,073 Cr | ₹1,895 Cr |
| Operating Profit (Excl OI) | ₹913 Cr | ₹722 Cr | ₹8,552 Cr | ₹525 Cr | ₹384 Cr |
| Other Income | ₹14 Cr | ₹18 Cr | ₹269 Cr | ₹37 Cr | ₹27 Cr |
| Interest | ₹56 Cr | ₹23 Cr | ₹263 Cr | ₹27 Cr | ₹28 Cr |
| Depreciation | ₹184 Cr | ₹159 Cr | ₹1,515 Cr | ₹137 Cr | ₹105 Cr |
| Profit Before Tax | ₹687 Cr | ₹558 Cr | ₹7,044 Cr | ₹451 Cr | ₹326 Cr |
| Profit After Tax | ₹517 Cr | ₹413 Cr | ₹5,495 Cr | ₹335 Cr | ₹236 Cr |
| Consolidated Net Profit | ₹517 Cr | ₹413 Cr | ₹5,495 Cr | ₹335 Cr | ₹236 Cr |
| Earnings Per Share (Rs) | ₹16.72 | ₹21.34 | ₹16.64 | ₹22.18 | ₹13.19 |
| PAT Margin (%) | 8.99 | 11.45 | 10.96 | 13.91 | 11.47 |
| ROE(%) | 13.46 | 19.18 | 17.49 | 27.64 | 20.06 |
| ROCE(%) | 15.66 | 19.63 | 17.37 | 25.42 | 18.19 |
| Total Debt/Equity(x) | 0.38 | 0.38 | 0.43 | 0.39 | 0.49 |
Key Financials |
||
| Market Cap | : | ₹ 11,812.2 Cr |
| Revenue (TTM) | : | ₹ 4,460.0 Cr |
| Net Profit(TTM) | : | ₹ 479.1 Cr |
| EPS (TTM) | : | ₹ 19.8 |
| P/E (TTM) | : | 24.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GRANULES INDIA | -4.7% | -5.2% | 13.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.8% | 7.6% | 8.4% |
| DIVIS LABORATORIES | -2.3% | 0.8% | 72.7% |
| CIPLA | -5.4% | -1.5% | 0.8% |
| TORRENT PHARMACEUTICALS | -0.8% | 6.8% | 25.6% |
| DR REDDYS LABORATORIES | -5.5% | 1.6% | -5.1% |
| MANKIND PHARMA | 2.1% | 3.7% | 9.5% |
| ZYDUS LIFESCIENCES | -4.4% | 0.4% | -12.5% |
| LUPIN | -4.5% | 6.9% | 25.2% |
GRANULES INDIA Revenues
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 19.84 % |
| 5 Yr CAGR | 18.62 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹4,512 Cr | 19.84 | |
| Mar2023 | ₹3,765 Cr | -88.37 | |
| Mar2022 | ₹32,375 Cr | 1,145.86 | |
| Mar2021 | ₹2,599 Cr | 14.02 | |
| Mar2020 | ₹2,279 Cr | - | |
GRANULES INDIA Operating Profit
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 26.56 % |
| 5 Yr CAGR | 24.18 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹913 Cr | 26.56 | |
| Mar2023 | ₹722 Cr | -91.56 | |
| Mar2022 | ₹8,552 Cr | 1,528.02 | |
| Mar2021 | ₹525 Cr | 36.79 | |
| Mar2020 | ₹384 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 5.58 % |
| 5 Yr CAGR | 4.69 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 20.24% | 5.58 | |
| Mar2023 | 19.17% | -27.44 | |
| Mar2022 | 26.42% | 30.66 | |
| Mar2021 | 20.22% | 20.00 | |
| Mar2020 | 16.85% | - | |
GRANULES INDIA Profit After Tax
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 25.16 % |
| 5 Yr CAGR | 21.58 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹517 Cr | 25.16 | |
| Mar2023 | ₹413 Cr | -92.49 | |
| Mar2022 | ₹5,495 Cr | 1,538.23 | |
| Mar2021 | ₹335 Cr | 41.87 | |
| Mar2020 | ₹236 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -21.48 % |
| 5 Yr CAGR | -5.91 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 8.99 % | -21.48 | |
| Mar2023 | 11.45 % | 4.47 | |
| Mar2022 | 10.96 % | -21.21 | |
| Mar2021 | 13.91 % | 21.27 | |
| Mar2020 | 11.47 % | - | |
GRANULES INDIA Earnings Per Share (EPS)
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | -21.65 % |
| 5 Yr CAGR | 6.11 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹17 | -21.65 | |
| Mar2023 | ₹21 | 28.25 | |
| Mar2022 | ₹17 | -24.98 | |
| Mar2021 | ₹22 | 68.16 | |
| Mar2020 | ₹13 | - | |
GRANULES INDIA Return on Capital Employed (ROCE)
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | -20.22 % |
| 5 Yr CAGR | -3.67 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 15.66% | -20.22 | |
| Mar2023 | 19.63% | 13.01 | |
| Mar2022 | 17.37% | -31.67 | |
| Mar2021 | 25.42% | 39.75 | |
| Mar2020 | 18.19% | - | |
GRANULES INDIA Share Price vs Sensex
| Current Share Price | : | ₹487.1 |
| Current MarketCap | : | ₹ 11,812.2 Cr |
| Updated EOD on | : | Mar 28,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -4.7% |
-5.2% |
13.3% |
| SENSEX | 0.7% |
4% |
6.3% |
GRANULES INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 1.5% | 3.4% | 7.5% |
| BSE 500 | 0.3% | 4.3% | 6.2% |
| BSE 500 SHARIAH | -0.2% | 1.8% | 0.3% |
| BSE 400 MIDSMALLCAP INDEX | -0.7% | 3.8% | 8.1% |
| BSE MIDSMALLCAP | -1.1% | 3.4% | 8.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 | 0.3% | 4.3% | 6.7% |
| NIFTY TOTAL MARKET | 0.2% | 4.1% | 6.8% |
| NIFTY500 MULTICAP 50:25:25 | -0% | 4.1% | 7.4% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -0.2% | 4% | NA |
| NIFTY MIDSMALLCAP 400 | -0.6% | 3.6% | 8.3% |
You may also like the below Video Courses
FAQ about GRANULES INDIA Financials
How the annual revenues of GRANULES INDIA have changed ?
The Revenues of GRANULES INDIA have increased by 19.84% YoY .
How the Earnings per Share (EPS) of GRANULES INDIA have changed?
The Earnings Per Share (EPS) of GRANULES INDIA has decreased by -21.65 % YoY .
Check out Intrinsic Value of Peers of GRANULES INDIA
Compare Stock Analytics of Peers of GRANULES INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
